Written by: Zhang Weilun
2020-01-30 10:12Last updated: 2020-01-30 10:13
Wuhan pneumonia continues to worsen, and pharmaceutical stocks are again sought after by investors today. Among them, China Medical Group (8225), which suspended its trading after a sharp rise of 2.8 times yesterday, pointed out that its clinical research group on new coronavirus pneumonia found that ritonavir had Coronavirus has inhibitory effect and efficacy report.
The company also pointed out that the affiliated company WanquanWant Xiamen is the only company that has produced this product in domestic history. The company also has raw material approvals, has applied for related patents, and has applied to the State Drug Administration to resume production. The company will be responsible for further Clinical research and application.
The company resumed trading this morning, seeing a high of 0.95 yuan, the latest reported 0.7 yuan, up 62.8%.
Tailing Pharmaceutical (1011) pointed out that it was concerned about reports that "ambroxol" may have potential for treating new coronaviruses, and pointed out that its subsidiary, Suzhou Yi Pharmaceutical, owns Zhuo Ao, an "ambroxol" drug. The company will pay close attention to the progress of the new coronavirus treatment method. Once it is confirmed that "ambroxol" can effectively treat the new coronavirus, the production department will fully cooperate with the Chinese government to produce Zhuoao in large quantities for market needs.
Tai Ling once saw a high of 0.495 yuan, the latest reported 0.395 yuan, up 36.2%.
Other pharmaceutical stocks have also been sought after. Yongsheng Medical (1612) hit a one-year high of as high as 0.96 yuan, the latest reported 0.9 yuan, up 28.6%, but Ge Li Pharmaceutical (1672) fell 11%, the latest reported 3.53 yuan.